Trials / Completed
CompletedNCT06130410
Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years
COMIRNATY Intramuscular Injection for 6 Months to 4 Years Old (Monovalent: Omicron XBB.1.5) Special Investigation for Booster Immunization in Children Aged 6 Months to 4 Years
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 6 Months – 4 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this post-marketing study is to assess the safety of Comirnaty monovalent XBB.1.5. for booster vaccination children ages 6 months though 4 years under actual use medical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | COMIRNATY intramuscular injection | Booster injection in the muscle, 1 dose |
Timeline
- Start date
- 2024-03-06
- Primary completion
- 2024-07-26
- Completion
- 2024-07-26
- First posted
- 2023-11-14
- Last updated
- 2025-07-14
- Results posted
- 2025-07-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06130410. Inclusion in this directory is not an endorsement.